NCT06655506 (ERGO) is a clinical trial of ERAS group in ERAS, sponsored by National and Kapodistrian University of Athens.

Who is sponsoring NCT06655506?

NCT06655506 is sponsored by National and Kapodistrian University of Athens.

What drugs are being tested in NCT06655506?

Interventions in NCT06655506: ERAS group, Control group.

What condition does NCT06655506 study?

NCT06655506 studies ERAS, Gynecologic Cancer, Perioperative Complication, Postoperative Pain, Quality of Life, Infections.

Is NCT06655506 still recruiting?

NCT06655506 is currently recruiting now. Last updated 23 October 2024.

Last reviewed 2024-10-23 · How we verify

NCT06655506: ERGO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhanced Recovery Protocols in Gynecologic Oncology

Recruiting now Last updated 23 October 2024

What this trial tests

trial testing ERAS group in ERAS in 600 participants. Currently enrolling.

Timeline

20 October 2024

Primary endpoint
31 March 2026

30 July 2026

Quick facts

Lead sponsor	National and Kapodistrian University of Athens
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	600
Start date	20 October 2024
Primary completion	31 March 2026
Estimated completion	30 July 2026
Sites	8 locations across Greece

Drugs / interventions tested

ERAS group
Control group — full drug profile →

Conditions studied

ERAS — all drugs for ERAS →
Gynecologic Cancer — all drugs for Gynecologic Cancer →
Perioperative Complication — all drugs for Perioperative Complication →
Postoperative Pain — all drugs for Postoperative Pain →

Sponsor

National and Kapodistrian University of Athens

Who can join

Adults 25 to 85, female only, with ERAS or Gynecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Enhanced Recovery After Surgery (ERAS) are developed to provide a systematic structure for managing postsurgical patients.These protocols promote evidenced-based practices and implement a multidisciplinary effort to maintain normal physiology in the perioperative period and aid in earlier recovery. The present study aims to investigate the feasibility of and compliance to a structured ERAS protocol among Gynecological Oncological Centers in Greece as well as to compare the outcomes among patients that fullfilled the minimum number of necessary criteria, compared to those that were enrolled in ERAS protocols but did not meet the sufficient necessary criteria.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Implementation Rates and Predictors of Compliance with Enhanced Recovery After Surgery Protocols in Gynecologic Oncology: A Prospective Multi-Institutional Cohort Study
Pergialiotis V, Haidopoulos D, Daponte A, Tsolakidis D, et al · · 2025 · cited 1× · DOI 10.20944/preprints202512.0014.v1
Implementation Rates and Predictors of Compliance with Enhanced Recovery After Surgery Protocols in Gynecologic Oncology: A Prospective Multi-Institutional Cohort Study.
Pergialiotis V, Haidopoulos D, Daponte A, Tsolakidis D, et al · · 2025 · PMID 41463241 · DOI 10.3390/cancers17243991

Verify or expand the search:

Other trials of ERAS group

Trials testing the same drug.

NCT03272984 — ERAS for Patients Received Neoadjuvant Chemotherapy · NA · completed

Other recruiting trials for ERAS

Currently open trials in the same condition.

NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
NCT07116564 — Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries · Phase 4 · recruiting
NCT07087366 — Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital · NA · recruiting
NCT06786819 — Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery B · NA · recruiting

Other National and Kapodistrian University of Athens trials

Trials by the same sponsor.

NCT07295964 — Accuracy of Intraoral Scan Post-processing Methods: A Clinical Trial · NA · not yet recruiting
NCT07351981 — TcPRF for Knee Osteoarthritis · NA · enrolling by invitation
NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
NCT07295899 — Assessing the Influence of Implant Scanning Techniques on the Accuracy of Maxillary Complete-Arch Digital Scans for Impl · not yet recruiting
NCT06903130 — Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sN · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06655506 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National and Kapodistrian University of Athens
Last refreshed: 23 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06655506.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing